NCT04026815

Brief Summary

The PolSenior2 survey is aimed to characterise health status of old and very-old adults in Poland.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 19, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

July 19, 2019

Status Verified

July 1, 2019

Enrollment Period

2 years

First QC Date

July 15, 2019

Last Update Submit

July 17, 2019

Conditions

Outcome Measures

Primary Outcomes (9)

  • Functional status as assessed by Vulnerable Elders Survey-13

    The Vulnerable Elders Survey-13 (VES-13) is a simple function-based tool for screening community-dwelling populations to identify older persons at risk for health deterioration. The VES-13 considers age, self-related health, limitation in physical function, and functional disabilities. The total possible score ranges from 0 to 10, with higher scores indicating increased disability.

    baseline

  • Functional status as assessed by Instrumental Activity of Daily Living

    This will be assessed using the Instrumental Activity of Daily Living (IADL-Lawton) instrument. IADL evaluates independent living skills. Each activity has specific level of participation that can be selected. Scores range from 0 (low function, dependent) to 8 points (high function, independent).

    baseline

  • Functional status as assessed by Activity of Daily Living Index

    This will be assessed using the Activity of Daily Living (ADL-Katz Index) instrument. ADL evaluates functional status as a measurement of the patient's ability to perform activities of daily living. Each activity is rated as being completed independently or not. Scores range is 0-6 points, higher score is better.

    baseline

  • Mood deterioration incidence

    The Geriatric Depression Scale (GDS) is a 15-item self-report assessment designed specifically to identify symptoms of depression in the elderly. Participants are asked to respond by answering yes or no in reference to how they felt over the past 2 weeks. The score 5 and more suggests the suspicion of depression, higher scores indicate more severe depressive syndrome. The final diagnosis of depression needs clinical assessment.

    baseline

  • Cognitive functions as assessed by the Mini Mental State Examination

    The Mini Mental State Examination (MMSE) investigates specific cognitive functions. Scale range: 0-30. The score 23 and below indicates significant deterioration of cognitive functions and dementia. Score between 24-27 indicates mild cognitive impairment. Normal score ranges between 28-30.

    baseline

  • Cognitive functions as assessed by Clock Drawing Test

    The Clock Drawing Test is a test used for the assessment of cognitive impairment based on sketches of a clock completed by a patient. The assessment is based on identifying abnormalities in the drawings, which may include poor number positioning, omission of numbers, incorrect sequencing, missing clock hands and the presence of irrelevant writing. According to Sunderland the score is: 0-10. Higher score indicates normal cognitive functions.

    baseline

  • Comorbidities incidence

    the prevalence of comorbidities

    baseline

  • Nutritional status assessed by the Mini Nutritional Assessment questionnaire (MNA)

    The MNA is a validated nutrition screening and assessment tool that can identify geriatric patients age 65 and above who are malnourished or at risk of malnutrition. The Screening score(max. 14 points) is 12-14 points indicates "Normal nutritional status", 8-11 points indicates "At risk of malnutrition", 0-7 points indicates "Malnourished". For the full assessment there are proposed scores: 24 pts and more "Normal nutritional status"; 23,5-17 "At risk of malnutrition"; below 17 - malnourished"

    baseline

  • Sarkopenia incidence

    The prevalence of sarcopenia will be assessed by analysis of grip strength (use of dynamometer).

    baseline

Secondary Outcomes (8)

  • Number of drugs taken

    baseline

  • Medical care availability

    five years back from baseline

  • Quality of life as assessed by the World Health Organization Quality of Life Age (WHOQOL-AGE)

    baseline

  • Quality and patterns of sleep assessmed by the Pittsburgh Sleep Quality Index

    baseline

  • Alcohol abuse assessment

    baseline

  • +3 more secondary outcomes

Study Arms (7)

60 - 65 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

65 - 69 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

70 - 74 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

75 - 79 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

80 - 84 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

85 - 89 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

≥90 years

Subjects were selected using a three stage stratified and proportional random sampling in seven equally size (n=850) age groups: 60-65, 65-69, 70-74, 75-79, 80-84, 85-89, 90+ years.

Other: medical history, blood and urine tests

Interventions

The study protocol consists of questionnaires (medical, socio-economic, dietary), comprehensive geriatric assessment, physical examination, anthropometric and blood pressure measurements and laboratory tests.

60 - 65 years65 - 69 years70 - 74 years75 - 79 years80 - 84 years85 - 89 years≥90 years

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The research population is assumed to include 6000 individuals in seven equivalent age cohorts (60-64 years, 65-69 years, 70-74 years, 75-79 years, 80-84 years, 85-89 years, 90+ years old) with equal representation of males and females in each of them. Research participants were randomly recruited in a stratified, proportional draw. The pattern for respondent selection was designed to obtain a population representative for Polish old citizens.

You may qualify if:

  • over 60 years of age,
  • randomly selected from database of all Polish citizens,
  • consent to participate in the study.

You may not qualify if:

  • under 60 years of age,
  • no consent to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Gdańsk

Gdansk, Poland

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

36 ml of whole blood and 20 ml of urine samples

MeSH Terms

Conditions

Immune System DiseasesFrailtyHealth BehaviorPatient Acceptance of Health Care

Interventions

Health Records, PersonalBlood Specimen CollectionUrinalysis

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehaviorTreatment Adherence and Compliance

Intervention Hierarchy (Ancestors)

Medical RecordsRecordsData CollectionEpidemiologic MethodsInvestigative TechniquesSpecimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeClinical Chemistry TestsDiagnostic Techniques, Urological

Study Officials

  • Tomasz R. Zdrojewski, MD, Prof

    Medical University of Gdansk, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tomasz R. Zdrojewski, MD, Prof

CONTACT

Lukasz Wierucki, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D., Ph.D., Assoc. Prof.

Study Record Dates

First Submitted

July 15, 2019

First Posted

July 19, 2019

Study Start

January 1, 2018

Primary Completion

December 31, 2019

Study Completion

December 31, 2020

Last Updated

July 19, 2019

Record last verified: 2019-07

Locations